NCT02990468 - A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

February 21, 2020

Study Completion Date

March 31, 2022

Conditions

Head and Neck Cancer

Interventions

DRUG

BMX-001

Subcutaneous injection.

RADIATION

Radiation Therapy

Patients will receive standard dose intensity modulated radiation therapy (IMRT).

DRUG

Cisplatin

Cisplatin will be administered per institution's standard of care practice.

Trial Locations (4)

Duke University Medical Center, Durham

University of Florida- Gainesville, Gainesville

University of Nebraska Medical Center, Omaha

University of California San Francisco, San Francisco